Pre-Formulation / Formulation
Accelerate Drug Development with Eurofins CDMO
Eurofins CDMO (Contract Development & Manufacturing Organization) network of companies offers a comprehensive drug development package for both new chemical entities and biologic compounds. Our services encompass the entire drug development journey, starting from preclinical development and extending to early clinical phases. We further support GMP production of small commercial batches, facilitating the accelerated development and manufacturing of their drugs.
At Eurofins CDMO, we specialize in developing innovative formulations that provide solutions to enhance bioavailability and control drug release, especially for challenging-to-formulate drug candidates. With over two decades of experience in drug development and manufacturing and a global presence with state-of-the-art facilities, we deliver high-quality, customized solutions for complex products and unique production processes.
Diverse Drug Product Development and Manufacturing Technologies
Our expertise extends to a wide range of drug product development and manufacturing technologies, enabling us to produce various liquid, solid, and semi-solid dosage forms for oral, nasal, buccal, and topical delivery. The drug products we develop can be easily scaled-up for clinical trial manufacturing, allowing for seamless transitions from development to GMP manufacturing.
Within our GMP-compliant manufacturing facilities, we offer clinical trial manufacturing of non-sterile liquid, semi-solid, and solid dosage forms, adhering to the requirements of Good Manufacturing Practices (GMP). We have the capabilities to manufacture immediate and controlled release delivery systems, catering to diverse drug formulation needs.
GMP Production Capabilities
Eurofins CDMO network of companies prides itself on its GMP production capabilities that comply with pharmaceutical industry standards. Our manufacturing capabilities cover various drug product types, including solutions, suspensions, emulsions, semi-solids, capsules, and tablets. We can produce batches ranging from 5 ml up to 50 L for solutions and suspensions, and from 5 g to 50 kg for semi-solids. Additionally, our capacity for capsules and tablets allows for batch sizes from 100 up to 200,000 units.
Beyond the manufacturing process, we prioritize the release and stability evaluation of the drug products we produce. Our testing methodologies include Accelerated Stability Studies, ICH stability testing, and the ASAP (Accelerated Stability Assessment Program). These evaluations ensure that the manufactured drug products meet the required quality standards and remain stable throughout their shelf life.
Partner with Eurofins CDMO for Your Pharmaceutical Success
Choose Eurofins CDMO as your partner to expedite drug development and manufacturing with the assurance of GMP compliance. Our comprehensive drug development solutions, coupled with our cutting-edge GMP manufacturing facilities, enable you to navigate the complexities of the pharmaceutical industry with ease.
Fill in the contact form below to start your journey towards accelerated drug development and seamless GMP production with Eurofins CDMO.
First episode of our new series:
"Voice of our experts"!
Listen to Maarten AERTS, our expert in Mass Spectrometry and learn why using this technology at the early stage of development:
